Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

160 Press Releases
DateTitleCompany
19 May 16 Astellas Oncology Announces Data to be Presented at 2016 ASCO Annual Meeting Astellas Pharma Inc.,
Published by
PR Newswire
12 May 16 Astellas' Dr. Anne Keating named Healthcare Businesswomen's Association Luminary Astellas,
Published by
PR Newswire
28 Apr 16 Astellas names Rodrigo Fernandez Executive Director, International Business Astellas,
Published by
PR Newswire
27 Apr 16 Astellas and the CNTRP Continue Partnership and Commitment to Canadian Research Innovation Astellas Pharma Canada, Inc.,
Published by
PR Newswire
25 Apr 16 Astellas Announces Key Leadership Appointments in Ethics and Compliance and US Legal Organizations Astellas,
Published by
PR Newswire
22 Apr 16 Astellas Pharma Canada Named as a Great Place to Work® Astellas Pharma Canada, Inc.,
Published by
PR Newswire
08 Apr 16 CHMP Issues Positive Opinion to Include New Data in European Label for XTANDI® (enzalutamide) Astellas Pharma,
Published by
PharmiWeb.com
08 Apr 16 Astellas Announces Key Leadership Appointments in Corporate Development Astellas ,
Published by
PharmiWeb.com
07 Apr 16 Astellas Announces Key Leadership Appointments in Corporate Development Astellas,
Published by
PR Newswire
06 Apr 16 Astellas Appoints Joseph Fleishaker to Lead Clinical Pharmacology and Exploratory Development Astellas,
Published by
PR Newswire
30 Mar 16 Astellas and Mitsubishi Tanabe Pharma Execute Agreement for Share of Compound Libraries Astellas ,
Published by
PharmiWeb.com
29 Mar 16 POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY EVALUATING ROMOSOZUMAB IN MEN WITH OSTEOPOROSIS Astellas BioPharma ,
Published by
PharmiWeb.com
25 Mar 16 Pivotal Phase III Trial of enzalutamide Initiated in Metastatic Hormone Sensitive Prostate Cancer Astellas,
Published by
PharmiWeb.com
04 Mar 16 Astellas Pharma Europe Ltd. Announces New President of EMEA Operations Astellas Pharma EMEA,
Published by
PR Newswire
03 Mar 16 Astellas promotes Catherine Wertjes to Head of Ethics & Compliance Astellas ,
Published by
PharmiWeb.com
25 Feb 16 FDA Accepts For Review Supplemental New Drug Application for XTANDI® (enzalutamide) Capsules in Metastatic Castration-resistant Prostate Cancer with Data from Head-to-Head Studies of Enzalutamide Versus Bicalutamide Astellas Pharma ,
Published by
PharmiWeb.com
24 Feb 16 Britain Facing Social Care 'Time-bomb' with Thousands of People Underprepared to Look After Themselves in Old Age Astellas Pharma Europe Ltd.,
Published by
PR Newswire
10 Feb 16 Astellas Names James Robinson President, Americas Operations Astellas ,
Published by
PharmiWeb.com
08 Feb 16 Astellas Names James Robinson President, Americas Operations Astellas Pharma Inc.,
Published by
PR Newswire
23 Nov 15 Astellas Announces Results from the First Head to Head Study Comparing QUTENZATM (Capsaicin 8% Patch) with Current Standard of Care in Patients with Peripheral Neuropathic Pain Astellas ,
Published by
PharmiWeb.com
11 Dec 15 Astellas Announces Publication of CRESEMBA® (Isavuconazonium Sulfate) Pivotal Phase 3 Study Results in The Lancet Astellas ,
Published by
PharmiWeb.com
30 Nov 15 Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan Ironwood Pharmaceuticals, Inc. and Astellas Pharma Inc.,
Published by
Business Wire
03 Dec 15 Astellas and Ironwood Report Positive Top-Line Data from Phase III IBS-C Trial Conducted in Japan Astellas ,
Published by
PharmiWeb.com
18 Dec 15 Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics Astellas ,
Published by
PharmiWeb.com
21 Dec 15 Astellas to Present at J.P. Morgan Healthcare Conference Astellas ,
Published by
PharmiWeb.com
06 Dec 15 Astellas Announces Updated Data from the Phase 1/2 CHRYSALIS Trial for Gilteritinib (ASP2215) in Patients with Relapsed or Refractory Acute Myeloid Leukaemia Astellas Pharma Europe,
Published by
Business Wire
14 Jan 16 Astellas Pharma Europe: Lancet Oncology Publishes Results from the Phase 2 TERRAIN Trial of Enzalutamide Compared to Bicalutamide in Metastatic Castration-Resistant Prostate Cancer Astellas Pharma Europe,
Published by
Business Wire
22 Jan 16 Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics Astellas Pharma Inc.,
Published by
PR Newswire
10 Dec 15 Astellas Announces Updated Data from the Phase 1/2 CHRYSALIS Trial for Gilteritinib (ASP2215) in Patients with Relapsed or Refractory Acute Myeloid Leukaemia Astellas ,
Published by
PharmiWeb.com
11 Dec 15 Bellicum and Astellas Announce License Agreement for Cancer Target PSCA in Cell and Gene Therapy Astellas ,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.